ΑΝΑΒΑΘΜΙΣΕΙΣ-ΥΠΟΒΑΘΜΙΣΕΙΣ-ΕΝΑΡΞΗ ΚΑΛΥΨΗΣ:
* Novartis Rated New Buy at Citi; PT 133 Swiss francs
* AstraZeneca Rated New Buy at Citi; PT 17,000 pence
* Roche Rated New Buy at Citi; PT 400 Swiss francs
* Burberry Raised to Overweight at Barclays; PT 1,450 pence
* Credit Agricole raised to outperform at Oddo BHF; PT 20 euros
* Eurobank raised to outperform at Mediobanca SpA; PT 4.70 euros
* Fielmann Reinstated Buy at Berenberg; PT 56 euros
* Mowi Raised to Buy at Arctic Securities; PT 235 kroner
* Hexatronic raised to buy at ABG; PT 30 kronor
* St James’s Place Raised to Buy at BofA
* Quilter Raised to Buy at BofA
* Redeia raised to buy at Bestinver; PT 16.50 euros
* Fjord Defence Group ASA reinstated buy at Pareto Securities
* ING reinstated buy at Jefferies; PT 27 euros
* Sanofi Reinstated Neutral at Citi; PT 85 euros
* Novo Rated New Neutral at Citi; PT 400 kroner
* Serco Cut to Add at Peel Hunt; PT 329 pence
* Cloudberry Clean Energy raised to hold at SEB Equities
* Elia Group raised to accumulate at KBC Securities; PT 135 euros
* Computacenter Cut to Neutral at Cantor; PT 3,500 pence
* GSK Rated New Neutral at Citi; PT 1,900 pence
* Austevoll Seafood Cut to Hold at Arctic Securities; PT 98 kroner
* Sampo raised to accumulate at Inderes; PT 10 euros
* BASF PT Cut to Street Low (€36) as JPMorgan Downgrades Outlook Again
* Siemens Cut to Reduce at Kepler Cheuvreux; PT 230 euros
Top News
* Roche says its investigational dual GLP-1/GIP receptor agonist CT-388 achieved a statistically significant placebo-adjusted weight loss of 22.5% at 48 weeks in a Phase II clinical trial of people living with obesity, according to a statement,
* Puma gains 16% on Tradegate before European markets open on Tuesday after China’s Anta Sports Products agreed to buy a stake of about 29% in Puma for €1.5 billion, becoming the biggest shareholder. ** Pinault Family Sells Puma Stake to China’s Anta for $1.8 Billion
* Citi starts coverage of the “big six” European pharmaceuticals firms, taking a positive sector view and installing AstraZeneca and Novartis as top picks,
*European car sales grew for a third year in a row in 2025 as consumers snapped up more affordable electric and hybrid models.
11:35 π.μ.